Kendley (603987): Leading domestic puncture device layout, medical aesthetics, welcome a new round of growth
Condeley (603987): Overseas inventory removal is coming to an end, Q3 is expected to improve marginally
Kendley (603987): Steady growth in 2022 performance exceeding expectations after deducting non-profit growth in 2023Q1
Kendley (603987): The 22-year results were under short-term pressure, and the 23Q1 performance recovered rapidly
Kendley (603987): The gradual formation of a diversified industrial pattern is expected to accelerate the release of medical and aesthetic products
Kendley (603987): Q3 performance fell short of expectations for steady growth in overseas business
Kandley (603987): Regular business growth of the same caliber is steady, and net profit margins remain at a high level in history
Candley (603987): 2022Q2 performance increases steadily and new products are expected to be launched in the second half of the year
Kendley (603987): Steady growth under the pandemic, leading product lines continue to be rich
Kandley (603987): Q2 deducted non-net profit performance is impressive, and the layout of platform-type piercing devices highlights growth resilience
Kangdelai (603987): stable operation under the epidemic and optimistic about accelerating growth in the second half of the year.
Kangdelai (603987): continuous iteration of products promotes the rapid growth of net profit from homecoming.
Kandelai (603987): the product line continues to enrich and its performance at home and abroad has increased.
Candley (603987): 22Q1 performance is in line with expected high growth for the whole year
Kandelai (603987): sustained and rapid growth of new products to promote development
Kangdelai (603987): high growth and low cost in the first quarter plus innovation and upgrading to build long-term core competitiveness
Kangdelai (603987) 2021 Annual report comments: the main business continues to grow overseas performance is outstanding
Kangdelai (603987): core business growth, stable operation quality and steady improvement
Kendley (603987): High growth in syringes, profit margins continue to rise in overseas markets
Kangdelai (603987) company comment report: product line continues to upgrade and expand to contribute to sustained high growth
No Data
No Data